Mission BioCapital is a venture capital firm dedicated to making pivotal early-stage investments in life sciences companies. Founded in 2009, the firm has established offices in Cambridge, Massachusetts, and San Francisco, California, two of the nation's leading life science clusters. Mission BioCapital supports its portfolio companies through a unique combination of shared lab space, capital investment, and access to strategic partners, assisting entrepreneurial scientists in building successful companies from idea to exit.

The firm's investment focus includes therapeutics, diagnostics, medical devices, laboratory tools, and drug delivery. In addition to traditional investments, Mission BioCapital emphasizes company creation by collaborating with academic researchers and entrepreneurs to launch startups based on novel technologies. This approach has led to the establishment of several companies, including ARase Therapeutics, Arclight Therapeutics LLC, Jupiter Bioventures, and Telo Therapeutics.

The firm's commitment to fostering innovation is further demonstrated through initiatives like the Platinum Program, which provides resources such as seed capital, lab space, and mentorship to accelerate the development of transformative life sciences startups.